新東方(09901.HK)推首款原創AI教育產品「新東方AI 1對1」
新東方(09901.HK)近日在面向消費者的To C領域推出首款原創AI教育產品——新東方AI 1對1,給學習者提供高頻互動的1對1學習體驗,透過AI老師還原真實學習場景,真互動、真問答。同時,AI老師具備耐心、責任心,精通教學,還能及時給出反饋,及時對學生進行表揚和鼓勵。
新東方教育科技集團CEO周成剛認爲,AI 1對1的學習路徑打破傳統教育的時空限制與成本壁壘,令學習的工具和產品更加豐富。新東方將在AI賦能教育方面持續探索,希望從當下的「一小步」發展成爲未來教育變革的「一大步」。
據悉,新東方AI 1對1將於7月2日正式上線,用戶可通過「新東方一點一看」APP訪問和使用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.